Private Label Nexium OTC Buoys Perrigo As Pricing Trims Rx Revenues
This article was originally published in The Pink Sheet
Executive Summary
Perrigo's third-quarter launch of private label Nexium24HR was primary contributor of $13m in new product sales in North America.